Faecalibacterium prausnitzii Is Associated With Clinical Response to Immune Checkpoint Inhibitors in Patients With Advanced Gastric Adenocarcinoma: Results of Microbiota Analysis of PRODIGE 59-FFCD 1707-DURIGAST Trial
Year: 2024
Type: article
Abstract: of stools, HER2 status, primary tumor site, tumor subtype, combined positive score PD-L1, and tumor proportion score PD-L1.P values were then adjusted using the Benjamini-Hochberg P value correction method.
Source: Gastroenterology
Authors: Marius Bredon, Karine le Malicot, Christophe Louvet, Ludovic Evesque, Daniel Gonzalez, David Tougeron, Harry Sokol
Institutions: Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine, Centre de Recherche Saint-Antoine, Fédération Francophone de Cancérologie Digestive, Centre de recherche Translationnelle en Médecine moléculaire, Institute Mutualiste Montsouris, Centre Antoine Lacassagne, Centre Hospitalier Universitaire de Poitiers, AgroParisTech, Université Paris-Saclay, Microbiologie de l’alimentation au service de la santé, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,180
Funder: Sorbonne Université
OpenAlex ID: W4403695833